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Klippel-Feil syndrome is clinically characterized by a short neck, low posterior hairline and limited neck 
movement.
Conclusions: The present study provides sufficient evidence that KFS is caused by a mutation 
in the MEOX1 and GDF3,GDF6 genes. This issue which has a scientific and clinical interest require an 
interdisciplinary approach that will ensure efficient planning of resources with involving of a 
performance type of management aimed to improve the situation in this category of patients as soon as 
possible.
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Background. There is growing evidence that high interindividual variability in response to 
blood-lowering medications is partially explained by genetic factors. Multiple genes, encoding blood 
pressure-regulating drug receptors and receptor response mechanisms are Associated with different 
results in achieving target BP values under antihypertensive treatment. Despite some consistent research, 
showing that various genetic single-nucleotide polymorphisms (SNP) may affect antihypertensive 
treatment efficacy, study results in this field continue to be conflicting and provide disparate results [1].
Aldosterone is the key mineralocorticoid rennin-angiotensin-aldosteron system (RAAS) hormone, 
affecting distal nephron to regulate sodium resorption, excretion of potassium, and intravascular volume. 
So the associations between aldosterone synthase gene polymorphism and hypertension would thus be 
of significant interest. Studies about the potential role of aldosterone synthase gene CYP11B2 (-344T/C) 
polymorphism and primary hypertension demonstrated controversial results. Some results indicate that 
-344T/C polymorphism has an impact on hypertensive target organ damage and the response to 
antihypertensive drugs [2 YP11B2 (-344T/C) gene 
polymorphism is Associated with the antihypertensive response to diuretics and RAAS-inhibitors [5
Due to small study samples and controversial results, even in conditions of one population, it remains 
unclear, whether CYP11B2 -344T/C single-nucleotide polymorphism (SNP) affects antihypertensive 
treatment response and long-term treatment outcomes.
Gender-related aspects of hypertension is a research field based on physiological tendency of 
men to have higher BP values during the whole lifespan, regardless of race or ethnicity. Men also tend 
to have more modifiable risk factors, such as excessive alcohol consumption, smoking, poor diet, 
sedentary lifestyle, etc. [8] Highlighting mechanisms, underlying sex differences in hypertension may 
lead to development of tailored therapeutic strategies, adaptive to specific gender-related variables, thus 
improving treatment outcomes [9
Aim. Current study aimed to evaluate gender aspects of interindividual response to 
antihypertensive treatment along with the role of SNP CYPIIB2 -344C/T in achieving target BP levels.
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Patients and methods. 93 patients with primary hypertension, 33 men (35.5%) and 60 women 
(64.5%) were enrolled into the study. Such gender proportion does not demonstrate any preference for 
enrolling women, making the studied group peculiar. Patients with secondary hypertension and 
documented first line antihypertensive treatment intolerance were not included into the study. All 
patients underwent standard clinical evaluation. Classical cardiovascular risk factors were assessed: 
family history of hypertension (FHH), history of premature cardiovascular events (CVEs) (defined as an 
diet, daily sedentary time. Documented anamnesis of polycystic ovary syndrome (PCOS), gestational 
hypertension, preeclampsia and eclampsia, surgical menopause and hypertension in menopause were 
assessed in women. Concomitant clinical conditions, such as obesity, type 2 diabetes mellitus were also 
taken into consideration. 
SNP CYPIIB2 -344C/T was assessed with polymerase chain reaction restricition fragment length 
polymorphism method (PCR-RLFP). Genetic material was obtained with buccal swab after obtaining 
patient’s informed consent. Epithelial cell deoxyribonucleic acid (DNA) extraction was performed with 
modified method, using Chelex solution [11]. Concentration and purity of a DNA-sample was assessed 
with spectrophotometry (Nanophotometr, Implen), after aliquot withdrawal directly from the vial with 
DNA solution. CYP11B2 (- -RFLP. Amplification 
was performed with CFX96-amplifier (BIO-
100 nm of each oligonucleotide primer, 100
stained with ethidium bromide, applying electrophoresis visualized under UV-light. Products of 
amplification were identified with DNA molecular mass marker pUC19: Msp1.
Obtained data was statistically processed with the use of STATISTICA 10.0 software (StatSoft, 
USA). Frequency data were analyzed by Fisher exact p method, two-tailed. P values p<0,05 were 
considered statistically significant. 
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Figure 1. End-stage PCR RFLP products, electrophoresis in agarose gel.
M – DNA molecular mass marker, tracks numbered 1-15 represent corresponding DNA samples.
Results. Approximately one third (11; 33,3%) of men enrolled into the study controlled BP 
effectively under the treatment. Proportion of women with proper BP control was significantly higher 
(p=0,03), more than half of women (34; 56,7%) had proper office BP levels. Groups of men and women 
were comparable between each other according to the mean quantity of prescribed medications, type of 
combination, administered in order to reduce BP. Remarkably, equally men and women, who did not 
Women with lack of proper BP control had significantly higher rate of concomitant type 2 diabetes 
mellitus, than women with target BP levels under antihypertensive treatment. 
Table 1. 
Risk factors
Hg
(n=32)
(n=23)
P
FAH, % 90,6 91,3 1
FH of premature CVE, 
%
37,5 39,1 1
Smoking, % 18,8 86,9 0,001
Excessive alcohol 
intake, %
0 43,5 0,001
Sedentary lifestyle, % 46,9 39,1 0,59
Excessive salt intake, % 50 65,2 0,28
Excessive intake of 
saturated and trans-fats, 
%
75 82,6 0,28
Obesity, % 71,9 56,5 0,26
Type 2 diabetes 
mellitus, %
46,9 39,1 0,59
Comparing subgroups of men and women with inadequate response to antihypertensive therapy 
by major cardiovascular risk factors showed that men with poor BP control have had some statistically 
significant differences with women, not achieving target BP levels. Men have had a current status of 
smoker significantly along with the excessive alcohol intake more often, than women (p=0,001; p=0,001, 
correspondingly). 
Genotyping demonstrated, that the men were CYPIIB2 -344C/T CC-genotype carriers less often, 
then women (p=0,03), while differences between gender groups regarding heterozygous genotype and 
TT-genotype were insignificant (see Table 2).
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Table 2. 
CYPIIB2 -344C/T 
haplotype
Female hypertensive 
patients (n=60)
Male 
hypertensive patients 
(n=33)
P, two-tailed, Fisher 
method
CC, % 28,3 9,1 0,03
CT, % 27; 45 21; 63,6 0,08
TT, % 16; 26,7 9; 27,3 0,95
Analyzing women’s cardiovascular risk factors, that can have an implication in hypertension 
course and outcomes no statistically significant differences were found between women who properly 
controlled BP under treatment and those, who did not achieve BP goals. Women with CC-genotype of 
CYPIIB2 gene demonstrated high rates of hypertension occurrence during the menopause (see Table 3). 
Table 3. 
Risk factors Women with 
CC-genotype
(n=17)
Women with 
TT-genotype
(n=16)
P, two-tailed, Fisher method
PCOS 1 (5,9%) 1 (6,3%) 1
Gestational hypertension 5 (29,4%) 3 (18,8%) 0,688
History of preeclampsia and/or eclampsia 1 (5,9%) 1 (6,3%) 1
Surgical menopause 1 (5,9%) 1 (6,3%) 1
Hypertension in menopause 11 (64,7%) 4 (25%) 0,037
Conclusions. Thus, study results showed that proportion of men, tending to control BP levels 
under prescribed treatment was lower than in women. Traditional cardiovascular risk factors analysis 
showed an association between family history of premature cardiovascular events and improper BP 
control in both men and women, receiving adequate and comparable antihypertensive treatment. 
Comparison for the rate of cardiovascular risk factors within gender subgroups, experiencing inadequate 
BP control under treatment demonstrated high rates of current smokers and alcohol abuse in males.
Gender groups demonstrated statistically significant difference in C-monozygous genotype rate, 
representing men to be T-allele carriers more often than women. Carrying CYPIIB2 -344C/T CC-
genotype was a factor, Associated with high rate of hypertension during the menopause, pointing 
towards special attention for women with certain gene-environmental interaction, regarding BP control 
and cardiovascular prevention.
Keywords: aldosterone synthase gene CYPIIB2 -344C/T polymorphism, antihypertensive 
treatment, classic modifiable and non-modifiable risk factors, gender.
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